CytoSorbents Corp (CTSO)
0.895
-0.05
(-5.78%)
USD |
NASDAQ |
Nov 15, 16:00
0.9251
+0.03
(+3.36%)
After-Hours: 20:00
CytoSorbents Revenue (Annual): 31.08M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.08M |
| December 31, 2022 | 29.36M |
| December 31, 2021 | 40.11M |
| December 31, 2020 | 39.45M |
| December 31, 2019 | 22.77M |
| December 31, 2018 | 20.25M |
| December 31, 2017 | 13.38M |
| Date | Value |
|---|---|
| December 31, 2016 | 8.206M |
| December 31, 2015 | 4.056M |
| December 31, 2014 | 3.145M |
| December 31, 2013 | 0.8218M |
| December 31, 2012 | 0.1516M |
| December 31, 2011 | 0.0361M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
22.77M
Minimum
2019
40.11M
Maximum
2021
32.55M
Average
31.08M
Median
2023
Revenue (Annual) Benchmarks
| Delcath Systems Inc | 2.065M |
| Star Equity Holdings Inc | 45.78M |
| Exact Sciences Corp | 2.500B |
| Illumina Inc | 4.504B |
| Progyny Inc | 1.089B |